Mar 28 |
Pyxis Oncology: Data Arriving Later Than Expected, But May Be Worth The Wait
|
Mar 27 |
Pyxis Oncology files to sell 10.46M common shares for holders
|
Mar 27 |
Pyxis Oncology gets $8M payment for sale of royalty rights
|
Mar 27 |
Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights
|
Mar 22 |
Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
|
Mar 21 |
Pyxis Oncology GAAP EPS of -$1.85 beats by $0.10
|
Mar 21 |
Pyxis Oncology Inc (PYXS) Reports Encouraging Clinical Progress Amid Financial Challenges
|
Mar 21 |
Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023
|
Mar 13 |
Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA
|
Mar 7 |
Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024
|